Patent · US Active

Strains of bifidobacterium having the ability to produce glutamine

US7947482B2 · kind B2 · utility

15Cited by

4References

3Claims

0Family size

Assignee

PROBI AB · SE

Inventors

Goran Molin · Bjärred, SE
Siv Ahrne · Bjärred, SE
Bengt Jeppsson · Lund, SE

Key dates

Filing date	Jan 27, 2004
Grant date	May 24, 2011
Priority date	—
Expiry date	Jul 9, 2026

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention refers to new strains of Bifidobacterium, especially of the species Bifidobacterium infantis, having the ability to survive in the intestinal tract and to produce glutamine and optionally arginine in vivo, as well as to compositions comprising said strains.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.